
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
F-star, an invoX company, is a clinical-stage biopharmaceutical business pioneering bispecific antibodies in immunotherapy so more people with cancer can live longer and improved lives. F-star is committed to working towards a future free from cancer and other serious diseases through the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in treatments. F-star has four second-generation immunooncology therapeutics in the clinic, each directed against some of the most promising IO targets in drug development, including LAG-3 and CD137. F-stars proprietary antibody discovery platform is protected by an extensive intellectual property estate, with over 500 granted patents and...
Bispecific antibodies,immuno-oncology,immmunotherapy,oncology,cancer,tetravalent bispecifics,cancer research,biotech,immunology,and cns
F-star, an invox company operates in the Biotechnology industry.
F-star, an invox company's revenue is 11m - 100m
F-star, an invox company has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.